Cite
Low Dose Alemtuzumab without Methotrexate for Gvhd Prevention
MLA
Tsirigotis, Panagiotis Liga, Maria Triantafyllou, Evangellia and Sarantopoulos, Aggelos Gkirkas, Konstantinos Stamouli, Maria and Petevi, Kiriaki Spyridonidis, Alexandros. Low Dose Alemtuzumab without Methotrexate for Gvhd Prevention. Jan. 2016. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.od......2127..184bd83d83262b15e34c858d85579500&authtype=sso&custid=ns315887.
APA
Tsirigotis, P. L. M. T. E. and S. A. G. K. S. M. and P. K. S. A. (2016). Low Dose Alemtuzumab without Methotrexate for Gvhd Prevention.
Chicago
Tsirigotis, Panagiotis Liga, Maria Triantafyllou, Evangellia and Sarantopoulos, Aggelos Gkirkas, Konstantinos Stamouli, Maria and Petevi, Kiriaki Spyridonidis, Alexandros. 2016. “Low Dose Alemtuzumab without Methotrexate for Gvhd Prevention,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.od......2127..184bd83d83262b15e34c858d85579500&authtype=sso&custid=ns315887.